Welcome to our dedicated page for Healthy Extracts SEC filings (Ticker: HYEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthy Extracts Inc. filings document the company’s public reporting obligations, material transactions, governance changes, and corporate structure as a Nevada operating company. Recent records include a Form 12b-25 notification related to the company’s annual report timing and Current Reports on Form 8-K covering material definitive agreements and executive appointments.
The filing record includes disclosure of the Gummy USA acquisition, the issuance of common stock as transaction consideration, related ownership and anti-dilution provisions, and board and officer changes tied to the company’s operating structure. These filings provide formal records of capital-structure changes, management roles, and material events affecting the nutraceutical and oral-delivery business.
Healthy Extracts Inc. completed the acquisition of Adli Gummies Inc., which operates the Imaraïs Beauty brand, through its subsidiary Healthy Extracts Canada Inc. The company paid with two secured promissory notes totaling $794,000 and equity.
Equity consideration included 2,159,520 Class B shares of Healthy Extracts Canada issued to Aaron Hefter, exchangeable one-for-one into Healthy Extracts common stock, and 840,480 Healthy Extracts common shares issued to other Adli shareholders. In connection with the deal, 3,000,000 Healthy Extracts common shares held by CEO Donald Swanson were cancelled, and the shares issued under the acquisition equal about 17.76% of total common shares.
The equity issued in this transaction was an unregistered sale of securities relying on the Section 4(a)(2) exemption. As a material term of the deal, Adli’s CEO, Aaron Hefter, age 45, was appointed Chief Brand Officer of Healthy Extracts under a Consulting Agreement effective May 15, 2026.
Healthy Extracts Inc. reported higher sales but remained unprofitable for the three months ended March 31, 2026. Revenue rose to $1,610,744 from $931,280 a year earlier, lifting gross profit to $988,701 from $424,985. General and administrative expenses increased to $1,317,403, driven by higher advertising, consulting, salaries, and stock-based compensation. The company posted a net loss of $200,590, an improvement from a $398,860 loss, helped by a $283,019 gain from the change in fair value of derivative liabilities. Cash was $164,385 and total liabilities were $3,337,239, while accumulated deficit reached $20,322,053. Management highlights ongoing substantial doubt about the ability to continue as a going concern and plans to seek additional debt and equity financing.
Healthy Extracts Inc. files its annual report outlining a nutraceutical platform focused on heart, brain, immune and gummy-based delivery products, including the 2025 acquisition of Gummy USA, now HE Gummy USA.
The company remains unprofitable, with a cumulative net loss of $20,121,462 from inception to December 31, 2025 and cash of $146,935, leading auditors to raise substantial doubt about its ability to continue as a going concern. As of March 31, 2026, non‑affiliate equity had an aggregate market value of $4,083,170, based on a $2.00 share price and 16,890,868 common shares outstanding.
Management highlights high gross margins of roughly 60%–70%, a differentiated Citrus Bergamot ingredient with higher BPF potency than key competitors, patented brain-health formulations, and an exclusive gel-pack delivery agreement with GELS. Growth plans center on new products (gut health, hydration, weight management), expanded sales channels, influencer partnerships and further strategic acquisitions, while acknowledging intense competition, supplier concentration, regulatory risks and the need for additional financing.
Healthy Extracts Inc. submitted a Form 12b-25 notification that its annual report on Form 10-K for the period ended December 31, 2025 will be filed late. The company states the delay is "as a result of our acquisition of Gummy USA LLC late in the third quarter of 2025" and intends to file the subject Annual Report on Form 10-K on or before the fifteenth calendar day following the prescribed due date.
Healthy Extracts Inc. (HYEX) reported Q3 2025 results and closed a transformative equity transaction. Revenue for the quarter was $917,975 versus $744,916 a year ago, but the company posted a net loss of $395,394 after higher operating expenses. For the nine months, revenue reached $2,817,910 with a net loss of $727,133.
On July 19, 2025, HYEX agreed to acquire Gummy USA LLC and issued 13,075,920 common shares, representing 77.5% of the company after the deal. Following a rescission on September 26, 2025, the merger structure was revised and the shares were re‑issued effective October 1, 2025; the $23,536,656 related amount is presented as a long‑term investment pending consolidation analysis. Shares outstanding were 16,870,868 as of September 30, 2025.
Cash was $189,452, operating cash flow used was $202,634, and derivative liabilities were $557,997. Management disclosed substantial doubt about the company’s ability to continue as a going concern within one year.
Healthy Extracts Inc. completed the acquisition of Gummy USA LLC by merging it into a wholly owned subsidiary, HE Gummy USA, Inc. As consideration, the company issued 13,075,920 common shares to Gummy USA’s founder Donald Swanson, giving him 77.5% of the company’s outstanding common stock after the transaction and anti-dilution rights tied to 154,306 outstanding options and warrants.
The share issuance was an unregistered sale under Section 4(a)(2) of the Securities Act. Swanson was re-appointed as director, Chairman, and Chief Executive Officer, while Kevin “Duke” Pitts became President and Chief Operating Officer, and director William Bossung resigned. The company plans to file required Gummy USA financial statements and pro forma information in an amendment within 71 days.
Healthy Extracts Inc. reported a leadership change in its top executive roles. Effective September 16, 2025, Donald Swanson was appointed Chief Executive Officer, taking over the CEO position from Kevin “Duke” Pitts. At the same time, Kevin “Duke” Pitts was appointed President, replacing Donald Swanson in that role, and also became Chief Operating Officer. The company stated that there are no family relationships among its officers or directors.
Healthy Extracts Inc. reported a leadership change in its top executive roles. Effective September 16, 2025, Donald Swanson was appointed Chief Executive Officer, taking over the CEO position from Kevin “Duke” Pitts. At the same time, Kevin “Duke” Pitts was appointed President, replacing Donald Swanson in that role, and also became Chief Operating Officer. The company stated that there are no family relationships among its officers or directors.